Twinbeech Capital »

Aquestive Therapeutics shares owned by Twinbeech Capital

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Twinbeech Capital from 13F filings

Historical chart of Twinbeech Capital investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Twinbeech Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Twinbeech Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $54k 13k 4.26

More positions owned by Twinbeech Capital

Lowe's Companies (LOW)
Home Depot (HD)
Meta Platforms Cl A (META)
Nike CL B (NKE)
Sherwin-Williams Company (SHW)
Apple (AAPL)
Lauder Estee Cos Cl A (EL)
Palantir Technologies Cl A (PLTR)
Accenture Plc Ireland Shs Class A (ACN)
CSX Corporation (CSX)
S&p Global (SPGI)
ON Semiconductor (ON)
Atlassian Corporation Cl A (TEAM)
Las Vegas Sands (LVS)
L3harris Technologies (LHX)

View all positions for Twinbeech Capital

Top funds holding Aquestive Therapeutics

VR Adviser
Vanguard Group
Franklin Resources
Laurion Capital Management
BlackRock
Susquehanna International
Monashee Investment Management
Blue Owl Capital Holdings
Qube Research & Technologies
Altium Capital Management
Essex Investment Management
Woodline Partners
Velan Capital Investment Management
Vahanian & Associates Financial Planning
Geode Capital Management

View all funds holding Aquestive Therapeutics